Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers

R. L. Piekarz, R. Frye, M. Turner, J. Wright, S. Allen, M. H. Kirschbaum, J. Zain, M. Prince, L. Hutchins, L. C. Showe, W. D. Figg, T. Fojo, S. E. Bates

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers'. Together they form a unique fingerprint.

Medicine & Life Sciences